|
TRIM26 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.81680000000251E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.386900E-04 |
| Normal-vs-Stage2 |
1.360650E-04 |
| Normal-vs-Stage3 |
2.317900E-03 |
| Normal-vs-Stage4 |
2.821700E-02 |
| Stage1-vs-Stage2 |
2.271400E-01 |
| Stage1-vs-Stage3 |
2.935600E-01 |
| Stage1-vs-Stage4 |
2.117200E-01 |
| Stage2-vs-Stage3 |
9.209200E-01 |
| Stage2-vs-Stage4 |
5.421800E-01 |
| Stage3-vs-Stage4 |
5.830400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.10119999999314E-05 |
| Normal-vs-AfricanAmerican |
2.133700E-02 |
| Normal-vs-Asian |
4.206600E-01 |
| Caucasian-vs-AfricanAmerican |
3.768000E-01 |
| Caucasian-vs-Asian |
7.785600E-01 |
| AfricanAmerican-vs-Asian |
9.781200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8864799999907E-05 |
| Normal-vs-Female |
5.688400E-02 |
| Male-vs-Female |
3.350400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.146260E-02 |
| Normal-vs-Extreme_Weight |
7.96330000000234E-05 |
| Normal-vs-Obese |
4.071800E-02 |
| Normal-vs-Extreme_Obese |
5.239500E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.857800E-01 |
| Normal_Weight-vs-Obese |
3.911400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.973600E-01 |
| Extreme_Weight-vs-Obese |
1.983760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.443600E-01 |
| Obese-vs-Extreme_Obese |
1.866230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.274180E-01 |
| Normal-vs-Age(41-60Yrs) |
7.041500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.03650000005118E-06 |
| Normal-vs-Age(81-100Yrs) |
1.462510E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.031000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.756200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.056400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.955660E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.724000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.862800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.847900E-02 |
| Normal-VS-Type2 PRCC |
1.83620000004936E-06 |
| Normal-VS-KIRP CIMP |
5.26079999563223E-08 |
| Normal-VS-Unclassified PRCC |
2.962700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.778600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.082400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.002820E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.834100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.268000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.881500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.35800000000685E-06 |
| Normal-vs-N1 |
6.582400E-02 |
| Normal-vs-N2 |
8.649500E-02 |
| N0-vs-N1 |
2.749800E-01 |
| N0-vs-N2 |
2.288400E-01 |
| N1-vs-N2 |
2.026200E-01 |
|
|
